Common Denominators of Self-renewal and Malignancy in Neural Stem Cells and Glioma

Grzegorz Wicher,Karin Holmqvist,Karin Forsberg-Nilsson

DOI: https://doi.org/10.1007/978-94-007-2801-1_17

2011-12-19

Abstract:Regulation of neural stem cell number needs to be tightly controlled. Mutations affecting stem cells or progenitor cells may result in uncontrolled proliferation and ultimately cancer. A growing body of evidence suggests that this mechanism underlies the genesis of several brain tumors, e.g. gliomas. The most malignant form is called glioblastoma multiforme and unfortunately its prognosis remains poor. The concept of tumor-causing stem cell-like cells, also called cancer stem cells, in solid tumors has attracted a lot of interest over the last 5–10 years. A glioma-initiating cell bearing stem cell characteristics has been proposed as the origin of glioma, with the ability to seed new tumors through the capacity to evade chemotherapy and irradiation. This would be a unique feature for glioma-initiating cells, not shared by the bulk of tumor cells. Neural progenitors and glioma-initiating cells have several common traits, such as sustained proliferation and a highly efficient migratory capacity in the brain. There are similarities between then neurogenic niche where adult neural stem cells reside, and the tumorigenic niche. These include interactions with the extracellular matrix, and many of the matrix components are deregulated in glioma. The signaling pathways that are mutated in glioma are in general important neural stem cell pathways that regulate cell proliferation/self renewal, differentiation, migration and survival. Molecular changes in these pathways due to mutations are associated with brain tumor development and so present therapy targets. Novel molecular classification of glioblastoma gives hope for more stratified treatment, and we are hopefully on the threshold to patient-specific treatments which may finally change the outcome in this devastating disease.